| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.2 |